DRKS00016919已完成不适用
DR-brachytherapy with I-125-seeds for prostate cancer - Offenburg results: a retrospective analysis of 260 patients - LDR-BT-OG
Ortenau Klinikum Offenburg-Kehl, Standort St. Josefsklinik0 个研究点目标入组 260 人开始时间: 2019年4月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Male
入选标准
- •RETROSPECTIVE: LDR-brachytherapy (Low dose rate) for prostate cancer in Offenburg in the time from 2002 to 2017
排除标准
- •treatment after 09/2015
研究者
相似试验
进行中（未招募）
3 期
SHIP0804Prostate CancerJPRN-jRCTs031180256Egawa Shin420
已完成
3 期
RCT of Tri-Modalities with I-125 Brachy Therapy and EBRT and Short or Long Term Hormone Therapy for High-risk Localized Prostate CancerProstate CancerJPRN-UMIN000003992Kanazawa University Translational Research Informatices Center340
已完成
1 期
Brachytherapy using linked-seed for prostate cancer with one intermediate risk factor -multicenter phase I/II trialProstate cancerJPRN-UMIN000011500Osaka University Graduate School of Medicine, Radiation Oncology25
招募中
不适用
Focal Brachytherapy for localized prostate cancer diagnosed by saturation biopsyprostate cancerJPRN-UMIN000044790ara Medical University35
已完成
不适用
Dutasteride for biopsy-negative benign prostate hyperplasia - effects on cancer detection and aging male symptomsbiopsy-negative benign prostate hyperplasiaJPRN-UMIN000005288Department of Urology, University of Tokyo Hospital40